The successful treatment of a multidrug-resistant Achromobacter xylosoxidans corneal ulcer with topical meropenem

BMJ Case Reports
Shokufeh TavassoliKieren Darcy

Abstract

Microbial keratitis is a common corneal condition, with many known risk factors. We present a case of an 88-year-old female patient with a multidrug-resistant Achromobacter xylosoxidans corneal ulcer in a previously failed second penetrating keratoplasty, successfully managed with topical meropenem drops administered hourly around the clock, for five days preceding and then hourly day only, for five days following a repeat third penetrating keratoplasty. Topical meropenem 50 mg/mL was prepared by mixing a 500 mg vial of meropenem with 10 mL of sterile water with pharmacy advice that administration should be within an hour. To the best of our knowledge, this is the first report of the use of topical meropenem in the management of A.xylosoxidans keratitis. This case highlights the importance of the mean inhibitory concentrations for antibiotics when considering sensitivities. Topical meropenem may be a useful treatment option for multidrug-resistant bacterial corneal ulcers that are resistant to conventional therapy.

References

Sep 1, 1971·Japanese Journal of Microbiology·E Yabuuchi, A Oyama
Dec 2, 2006·Journal of Cataract and Refractive Surgery·Sathish SrinivasanAllan R Slomovic
Nov 6, 2009·International Journal of Antimicrobial Agents·Marisa AlmuzaraCarlos Vay
Dec 19, 2009·Investigative Ophthalmology & Visual Science·Henri SuekeChristopher Parry
Jul 29, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A-P MagiorakosD L Monnet
Sep 25, 2012·Journal of Cataract and Refractive Surgery·Francisco Arnalich-MontielJacob Lorenzo-Morales
Apr 4, 2013·Journal of Ophthalmic Inflammation and Infection·Megan ScottSteven Yeh
Sep 26, 2013·Journal of Refractive Surgery·Kamran M RiazSurendra Basti
Dec 10, 2014·Antimicrobial Agents and Chemotherapy·Yongfei HuBaoli Zhu
Mar 30, 2017·Eye & Contact Lens·Cristina Almenara MichelenaJose Ángel Cristóbal

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.